Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PALBOCICLIB

PALBOCICLIB

Standard Dose
100MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PALBOCICLIB is listed in Drugs@FDA under application 215570 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PALBOCICLIB Form and strength TABLET;ORAL - 100MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-06-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview PALBOCICLIB is listed in Drugs@FDA under application 215570 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PALBOCICLIB Form and strength TABLET;ORAL - 100MG Sponsor ZYDUS LIFESCIENCES Submission history Latest submission status date: 2024-06-05 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.